Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Sean Krohn, PharmD, CSP, MSCS

Articles by Sean Krohn, PharmD, CSP, MSCS

Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com

Advancing Pericarditis Care: The Evolving Role of IL-1 Inhibition and Pharmacist-Cardiologist Collaboration

ByKennedy Ferruggia, Assistant Editor,Luke Halpern, Assistant Editor,Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC,Sean Krohn, PharmD, CSP, MSCS

July 7th 2025

Experts discussed the promising future of pericarditis treatment.

Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com

Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies

ByKennedy Ferruggia, Assistant Editor,Luke Halpern, Assistant Editor,Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC,Sean Krohn, PharmD, CSP, MSCS

July 1st 2025

Pharmacists and clinicians collaborate to carefully manage rilonacept therapy.

Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

ByKennedy Ferruggia, Assistant Editor,Luke Halpern, Assistant Editor,Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC,Sean Krohn, PharmD, CSP, MSCS

June 11th 2025

Pharmacists play a critical role in managing complex pericarditis cases.

Image credit: Sebastian Kaulitzki | stock.adobe.com

Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations

ByKennedy Ferruggia, Assistant Editor,Luke Halpern, Assistant Editor,Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC,Sean Krohn, PharmD, CSP, MSCS

June 6th 2025

Rilonacept offers a targeted approach to treating recurrent pericarditis by blocking IL-1 inflammatory pathways.

Latest Updated Articles

Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
Published: June 6th 2025 | Updated:
Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment
Published: June 11th 2025 | Updated:

Trending on Pharmacy Times

A Multifaceted Approach to Navigating Career Transitions in Pharmacy

Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health

Menopause Care Varies by Provider, Highlighting Need for Standardized Education

© 2025 MJH Life Sciences^®

All rights reserved.